Vineet Laboratories Ltd.
NSE: VINEETLAB | BSE: 543298
₹35.00
₹0.15
(0.43%)
As on 27-May-2026IST
Market cap
₹67 Cr
Revenue (TTM)
₹55 Cr
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-10 Cr
-
ROE
-81.8 %
-
ROCE
-25.1 %
-
Industry P/E
36.8
-
EV/EBITDA
-30.3
-
Debt to Equity
2.7
-
Book Value
₹23.4
-
EPS
₹-11
-
Face value
10
-
Shares outstanding
19,206,266
8 Years Aggregate
CFO
₹30.38 Cr
EBITDA
₹19.87 Cr
Net Profit
₹-9.50 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vineet Lab
| -4.8 | -17.6 | 14.5 | 29.2 | -4.7 | -- | -- |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Vineet Lab
| -25.4 | -27.7 | 29.1 | -22.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vineet Lab
|
35.0 | 67.2 | 54.6 | -10.1 | -13.9 | -70.2 | -- | 1.5 |
| 1,070.3 | 13,138.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23.3 | 3.9 | |
| 470.3 | 8,160.7 | 947.3 | 247.8 | 28.5 | 18.9 | 32.9 | 6.0 | |
| 1,099.6 | 11,501.5 | 1,158.7 | 309.6 | 31.9 | 17.3 | 36.8 | 6.1 | |
| 1,725.3 | 32,703.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.4 | 6.6 | |
| 432.2 | 4,723.6 | 165.8 | 46.7 | 37.8 | 16.9 | 101.2 | 16.4 | |
| 16,772.0 | 21,502.1 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.1 | 11.5 | |
| 1,113.4 | 5,129.2 | 649.5 | 121.6 | 23.7 | 13.2 | 44.5 | 5.5 | |
| 674.7 | 7,616.1 | 502.0 | 138.7 | -- | 32.8 | 44.1 | 8.6 | |
| 267.2 | 7,038.7 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vineet Lab
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir,... Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India. Read more
-
Incorporated
2016
-
Chairman
Dilip Vishnu Acharekar
-
Managing Director
Gaddam Venkata Ramana
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Vineet Lab
What is the current share price of Vineet Laboratories Ltd Today?
The share price of Vineet Laboratories Ltd is ₹35.00 (NSE) and ₹35.00 (BSE) as of 27-May-2026 IST. Vineet Laboratories Ltd has given a return of -4.72% in the last 3 years.
What is the current PB & PE ratio of Vineet Laboratories Ltd?
Since, TTM earnings of Vineet Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Vineet Laboratories Ltd is 1.49 times as on 27-May-2026, a 35 discount to its peers’ median range of 2.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.92
|
|
2024
|
44.25
|
1.31
|
|
2023
|
30.22
|
1.12
|
|
2022
|
6.58
|
1.32
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Vineet Laboratories Ltd?
The 52-week high and low of Vineet Laboratories Ltd are Rs 43.50 and Rs 24.01 as of 28-May-2026.
What is the market cap of Vineet Laboratories Ltd?
Vineet Laboratories Ltd has a market capitalisation of ₹ 67 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vineet Laboratories Ltd?
Before investing in Vineet Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.